ASPC
NASDAQ · N/A
A Spac Iii Acquisition-Cl A
$10.87
+0.03 (+0.32%)
Open$10.87
Previous Close$10.84
Day High$10.87
Day Low$10.87
52W High$63.98
52W Low$10.30
Volume—
Avg Volume9.3K
Market Cap25.33M
P/E Ratio60.08
EPS$0.02
SectorN/A
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 8.50M | 7.85M | 8.29M |
| Net Income | 1.08M | 1.10M | 1.18M |
| Profit Margin | 12.8% | 14.0% | 14.3% |
| EBITDA | 2.43M | 1.87M | 2.14M |
| Free Cash Flow | 1.08M | 827.7K | 1.22M |
| Rev Growth | +23.2% | +3.0% | +8.6% |
| Debt/Equity | 0.81 | 0.71 | 0.73 |
N/A Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| EMAT | Evolution Metals & Technolog | $3.20 | +0.00% | — | 2.01B |
| PICS | Pics Nv | $8.32 | -4.26% | 4.4 | 1.13B |
| DMII | Drugs Made In America Acquis | $10.16 | +0.10% | 49.7 | 646.56M |
| CCCX | Churchill Capital Corp X-A | $10.08 | -5.62% | — | 2.32B |
| BEAG | Bold Eagle Acquisition Cor-A | $10.76 | +0.47% | 42.2 | 335.42M |
| CEPF | Cantor Equity Partners-Cl A | $10.30 | +0.15% | 41.3 | 587.79M |